OptimizeRx Introduces OptimizeMDs, a “Voice of the Physician” Multi-Specialty Digital Health Panel
07 Februar 2019 - 5:30PM
OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital
health messaging for the pharmaceutical industry, has formed
OptimizeMDs, a multi-specialty physician panel with the mission of
improving the effectiveness of digital health communications
delivered throughout the care continuum.
“OptimizeRx provides technology designed to streamline and
improve communications between pharma/life sciences, providers and
patients,” said Miriam Paramore, president of OptimizeRx. “We
established OptimizeMDs as a way to gather important and timely
information about the challenges physicians face with prescribing
decisions, medication affordability and patient support. We expect
the lessons learned from OptimizeMDs will help us further bridge
the communication gaps between pharma and provider and patient, and
ultimately improve affordability and adherence.”
Learning about these gaps in healthcare from the provider
perspective, the professional most closely linked to the patient,
is expected to provide powerful intelligence that pharmaceutical
manufacturers and EHR vendors can use to improve how and when they
digitally communicate.
Most pharmaceutical industry events geared towards better
engagement with healthcare providers rarely provide insights
directly from them. “At a recent pharma-hosted conference with over
4,000 attendees, I was surprised there was only one panel that
represented the voice of physicians,” noted Paramore. “Through
OptimizeMDs, we believe we can improve digital communication in
this important area by giving voice to physicians serving patients
at the point-of-care and beyond. We see this enhancing brand
awareness and product launches by providing our clients timely
access to valuable information and physician/patient feedback.”
More than 1,200 healthcare providers have already joined the
panel. They represent a broad range of practice sizes and settings,
allowing OptimizeMDs to provide statistically valid insights into
key questions that pharma, healthcare IT and others are looking to
address.
Physicians can join OptimizeMDs today by signing up at
info.optimizerx.com/optimizemds.
About OptimizeRxOptimizeRx® (NASDAQ: OPRX) is
one of the nation’s leading providers of digital health messaging
via electronic health records (EHRs), providing a direct channel
for pharma companies to communicate with healthcare providers. The
company’s cloud-based solution supports patient adherence to
medications by providing real-time access to financial assistance,
prior authorization, education, and critical clinical information.
The company’s network is comprised of leading EHR platforms like
Allscripts, Amazing Charts and Quest, and provides more than half
of the ambulatory patient market with access to these benefits
within their workflow at the point-of-care. For more information,
follow the company on Twitter, LinkedIn or
visit www.optimizerx.com.
Important Cautions Regarding Forward Looking
Statements Certain information contained in this press
release includes “forward-looking statements” within the meaning of
The Private Securities Litigation Reform Act of 1995, including
statements related to the proposed public offering, the filing of
the registration statement and potential market opportunity for our
product candidates. We may, in some cases use terms such as
“predicts,” “believes,” “potential,” “continue,” “anticipates,”
“estimates,” “expects,” “plans,” “intends,” “may,” “could,”
“might,” “will,” “should” or other words that convey uncertainty of
the future events or outcomes to identify these forward-looking
statements. Our forward-looking statements are based on current
expectations that involve risks, potential changes in
circumstances, assumptions and uncertainties. Any or all of the
forward-looking statements may turn out to be wrong, or be affected
by inaccurate assumptions we might make or by known or unknown
risks and uncertainties as a result of various important factors,
including the uncertainties related to market conditions, our
ability to satisfy the closing conditions of the offering, the
timing or occurrence of the closing, and the anticipated use of the
proceeds of the offering, which could change as a result of market
conditions or for other reasons. For a further description of the
risks and uncertainties that could cause actual results to differ
from those expressed in these forward-looking statements, as well
as risks relating to our business in general, please refer to our
prospectus supplement filed with the Securities and Exchange
Commission (SEC) on December 17, 2018 under the heading “Risk
Factors” and those documents incorporated by reference therein,
which includes our Annual Report on Form 10-K filed with the SEC on
March 8, 2018. You are cautioned not to place undue reliance on
these forward-looking statements, which are made only as of the
date of this press release. We undertake no obligation to publicly
update such forward-looking statements to reflect subsequent events
or circumstances.
OptimizeRx ContactDoug Baker, CFOTel (248)
651-6568 x807dbaker@optimizerx.com
Media Relations ContactNicole Brooks, Innsena
Communications(Tel) 860-800-2344nicolebrooks@innsena.com
Investor Relations ContactRon Both, CMATel
(949) 432-7557oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024